Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group

Media Article 25 Oct 2017

The Initiative for Medicines, Access & Knowledge, a nonprofit focused on how patents affect access to medicine, said that it’s filed petitions with the U.S. Patent Trial and Appeal Board seeking to challenge intellectual-property rights that would keep generic versions of Sovaldi from entering the market.

Partner with us now to build
a more just and equitable
medicine system for all.